EU: Xofigo for adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases, approved
Bayer HealthCare has announced that the European Commission ( EC ) has granted marketing authorisation for Xofigo 1000 kBq/ml, solution for injection ( Radium Ra 223 dichloride ) for the treatment of ...
read article